Louis J. DeBone, president and CEO for Mylan Laboratories, has announced plans to retire.
Glades Pharmaceuticals has announced the appointment of Darren Alkins to the position of president.
CoTherix has named Abhay Joshi, Ph.D. executive vice president and chief technical officer.
Pharsight Corporation has named Will Frederick as senior vice president and CFO.
Neuro-Hitech Pharmaceuticals has appointed David Barrett as its CFO.
The Avicena Group has named Michael Sullivan as the company's vice president of finance and acting CFO.
PRA International named Bruce Teplitzky executive vice president, business development.
New River Pharmaceuticals has hired John Thottathil, Ph.D., as chief scientific officer.
SeraCare Life Sciences has named Cathryn Low interim CFO.
ViaCell has named James Corbett president of ViaCell Reproductive Health.
RESPIRONICS has named David P. White, M.D., as chief medical officer.
Perceptive Informatics has hired Dr. James Paskavitz as medical director.
Invitrogen has named former NIH stem cell section chief Mahendra Rao, MD, Ph.D. vice president, research, stem cells and regenerative medicine.
Neuromed Pharmaceuticals has appointed Dr. Stephen Arneric vice president of research and preclinical development.
NanoInk has appointed JoAnne Smith Joyce as a member of the company's senior management team.
Exagen Diagnostics announced that Thomas O'Connor has joined the company as vice president, sales.
CMEA Ventures announced that Rodney D. Altman, MD will join its firm as senior partner.
MedPharm has appointed Dr. Geoffrey Vernon as chairman.
Vitae Pharmaceuticals has named Donald Hayden chairman of its board of directors.
Oxxon Therapeutics named Craig R. Smith, M.D. as chairman and John Berriman as executive deputy chairman of the company's board of directors.
Bayhill Therapeutics has named David E. Thompson to the Bayhill board as an independent director.
Indevus Pharmaceuticals has named Andrew J. Ferrara, founder and president of Boston Healthcare Associates, to its board.
Genomic Health has named Woodrow A. Myers, M.D., M.B.A. to its board of directors.
Anadys Pharmaceuticals has appointed Robert "Chip" Schooley, M.D., to its clinical and scientific advisory board.
Pro-Pharmaceuticals has nominated Dr. Henry Esber to its board of directors.
Savient Pharmaceuticals announced that Dr. Lee S. Simon, Mr. Alan L. Heller, and Mr. Joseph "Skip" Klein III, will stand for election as independent directors.
Phytomedics has named G. Steven Burrill to its board of directors.
Momenta Pharmaceuticals has elected Paul D. Goldenheim, M.D. to its board.
Xenomics has appointed Colin J. Foster to its board.
George Conrades has joined Microbia's board of directors.